All Pathways
OphthalmologyEmergency

Central Retinal Artery Occlusion (CRAO) Management

Central Retinal Artery Occlusion (CRAO) Management: Suspected CRAO → Symptom Onset <24 hours? → Activate Stroke Alert → Patient Age ≥50 years? → GCA Wor...

Interactive Decision Tree

Mini Map

Algorithm Steps

  1. Start

    Suspected CRAO

    Sudden, painless, monocular vision loss. Cherry-red spot, pallid retina, box-carring vessels on fundoscopy

    1. Decision

      Symptom Onset <24 hours?

      CRAO is a stroke equivalent. Irreversible retinal ischemia can occur in as little as 90 minutes

      1. Action

        Activate Stroke Alert

        CRAO = CNS infarction per AHA/ASA. Immediate referral to nearest stroke center for evaluation of acute intervention

        • Call stroke team/code stroke
        • Do NOT delay for ophthalmology workup
        • Stroke risk highest in first 2 weeks to 1 month
        1. Decision

          Patient Age ≥50 years?

          Giant cell arteritis (GCA) must be ruled out in older patients

          1. Action

            GCA Workup

            URGENT: Rule out giant cell arteritis to prevent contralateral vision loss

            • Check ESR, CRP immediately
            • Ask about headache, jaw claudication, scalp tenderness, PMR symptoms
            • If GCA suspected: start IV methylprednisolone 1g/day BEFORE biopsy
            • Arrange temporal artery biopsy within 2 weeks
            1. Action

              Systemic Stroke Evaluation

              Look for embolic source - carotid disease, cardiac source

              • Carotid ultrasound/CTA
              • Echocardiogram (TTE ± TEE)
              • ECG/Holter for AF
              • CBC, lipids, HbA1c, coagulation
              • Consider hypercoagulability panel if <50 years
              1. Warning

                ⚠️ Monitor for Neovascularization

                Increased risk of iris/retinal neovascularization after CRAO

                • Follow-up examination in 1-2 weeks
                • More frequent follow-up if greater ischemia
                • PRP if neovascularization develops
                1. Action

                  Secondary Stroke Prevention

                  Address modifiable risk factors to prevent future events

                  • Antiplatelet therapy (aspirin)
                  • Statin therapy
                  • Blood pressure control
                  • Diabetes management
                  • Smoking cessation
                  • Carotid endarterectomy if significant stenosis
                  1. Outcome

                    Acute Management Complete

                    Patient evaluated by stroke team. Etiology identified. Prevention measures initiated

                  2. Outcome

                    Retina Follow-up

                    Schedule retina clinic follow-up for neovascularization monitoring and visual rehabilitation

      2. Action

        Late Presentation (>24h)

        No proven treatments to reverse established vision loss. Focus on stroke prevention and etiology workup

Guideline Source

AAO Preferred Practice Pattern: Retinal and Ophthalmic Artery Occlusions 2024

Clinical Safety Information

Clinical Decision Support — Not a Substitute for Clinical Judgment

Individual patient factors may require deviation from these recommendations.

Known Limitations

  • Does not address branch retinal artery occlusion (BRAO) specifically
  • Treatment decisions for thrombolysis should involve stroke neurology
  • Pediatric and young adult CRAO requires additional hypercoagulability workup
  • Does not replace comprehensive stroke center evaluation

Applicable Regions

USEUGlobal

EU: Follow local stroke network protocols

US: AHA/ASA classify CRAO as CNS stroke - refer to stroke center

Version 1Next review: 2029-01-01

Frequently Asked Questions

What is the Central Retinal Artery Occlusion (CRAO) Management?

The Central Retinal Artery Occlusion (CRAO) Management is a emergency clinical algorithm for Ophthalmology. It provides a structured decision tree to guide clinical decision-making, based on AAO Preferred Practice Pattern: Retinal and Ophthalmic Artery Occlusions 2024.

What guideline is the Central Retinal Artery Occlusion (CRAO) Management based on?

This algorithm is based on AAO Preferred Practice Pattern: Retinal and Ophthalmic Artery Occlusions 2024 (DOI: 10.1016/j.ophtha.2024.12.024).

What are the limitations of the Central Retinal Artery Occlusion (CRAO) Management?

Known limitations include: Does not address branch retinal artery occlusion (BRAO) specifically; Treatment decisions for thrombolysis should involve stroke neurology; Pediatric and young adult CRAO requires additional hypercoagulability workup; Does not replace comprehensive stroke center evaluation. Individual patient factors may require deviation from these recommendations.

Get AI-Powered Analysis Alongside This Algorithm

In AttendMe.ai, the Central Retinal Artery Occlusion (CRAO) Management appears automatically when your clinical question matches — alongside evidence from 3M+ peer-reviewed articles.

Try AttendMe Free